Table 5.
Average partial effects of selected comorbidities on total costs (in CHF)
| Infectious diseases | Skin problems | Musculoskeletal diseases | Circulatory diseases | |||||
|---|---|---|---|---|---|---|---|---|
| APE | (SE) | APE | (SE) | APE | (SE) | APE | (SE) | |
| Psychiatric conditions | ||||||||
| Schizophrenia | 4576*** | (1681) | 1487* | (883) | 1005* | (536) | 1795 | (1452) |
| Mood disorder | 306 | (613) | 100 | (211) | 67 | (136) | 121 | (236) |
| Neurotic disorder | 1893*** | (607) | 621** | (316) | 419** | (210) | 753 | (623) |
| Behavioral syndrome | −287 | (552) | −94 | (180) | −63 | (126) | −113 | (247) |
| Personality disorder | 1318** | (586) | 431 | (286) | 291* | (164) | 521 | (449) |
| Mental retardation | 827 | (1166) | 271 | (383) | 183 | (254) | 327 | (541) |
| Substance abuse | ||||||||
| Alcohol | 95 | (379) | 31 | (126) | 21 | (83) | 37 | (149) |
| Illicit drugs | 853** | (372) | 275 | (180) | 185* | (109) | 331 | (303) |
| Pharmaceuticals | 2750** | (1017) | 894** | (427) | 602** | (305) | 1075 | (1058) |
N = 1107. Standard errors calculated with the delta-method. Length of stay in 2011 (exposure) taken into account
* p < 0.10, ** p < 0.05, *** p < 0.01